This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gerhardinger, C. Articles by Lorenzi, M. Search for Related Content PubMed PubMed Citation Articles by Gerhardinger, C. Articles by Lorenzi, M.

American Journal of Pathology, Vol 152, 1453-1462, Copyright © 1998 by American Society for Investigative Pathology

REGULAR ARTICLES

Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy

C Gerhardinger, LF Brown, S Roy, M Mizutani, CL Zucker and M Lorenzi
Department of Ophthalmology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

Vascular endothelial growth factor (VEGF)/vascular permeability factor is a likely angiogenic mediator in proliferative diabetic retinopathy, and its role is under scrutiny in the pathogenesis of the capillary leakage characteristic of background diabetic retinopathy. To examine whether the diabetic milieu induces or increases retinal VEGF expression in humans, we examined retinas from nondiabetic eye donors and donors with 9 +/- 5 years of diabetes and documented microangiopathy. To identify possible confounding effects of the postmortem period, we also studied the postmortem stability of the VEGF transcript and the expression of the VEGF protein in rat retinas. In both human and rat retina we detected by Northern analysis a 4.2-kb VEGF mRNA species and by reverse transcriptase polymerase chain reaction the transcripts encoding VEGF165 (the most abundant), VEGF121, and VEGF189. By in situ hybridization and immunohistochemistry VEGF mRNA and protein co-localized at the ganglion cell, inner nuclear, and outer plexiform layers and in the walls of the blood vessels (where mRNA was scarce). The protein was additionally detected in photoreceptors. The abundance and distribution of VEGF mRNA and protein were not altered in the diabetic retinas, indicating that the diabetic environment is not sufficient to increase retinal VEGF expression. The demonstration that VEGF is constitutively expressed in the adult retina and is localized to discrete neural cells and their processes proposes a role for the cytokine in retinal homeostasis and/or function.

This article has been cited by other articles:

				C. B. Lupien, C. Bolduc, S. Landreville, and C. Salesse Comparison between the Gene Expression Profile of Human Muller Cells and Two Spontaneous Muller Cell Lines Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5229 - 5242. [Abstract] [Full Text] [PDF]

				D. McLeod A chronic grey matter penumbra, lateral microvascular intussusception and venous peduncular avulsion underlie diabetic vitreous haemorrhage Br. J. Ophthalmol., May 1, 2007; 91(5): 677 - 689. [Abstract] [Full Text] [PDF]

				T. E. de Gooyer, K. A. Stevenson, P. Humphries, D. A. C. Simpson, T. A. Gardiner, and A. W. Stitt Retinopathy Is Reduced during Experimental Diabetes in a Mouse Model of Outer Retinal Degeneration Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5561 - 5568. [Abstract] [Full Text] [PDF]

				J. Gaudreault, D. Fei, J. Rusit, P. Suboc, and V. Shiu Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 726 - 733. [Abstract] [Full Text] [PDF]

				C. Gerhardinger, M. B. Costa, M. C. Coulombe, I. Toth, T. Hoehn, and P. Grosu Expression of Acute-Phase Response Proteins in Retinal Muller Cells in Diabetes Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 349 - 357. [Abstract] [Full Text] [PDF]

				Z. Duenas, J. C. Rivera, H. Quiroz-Mercado, J. Aranda, Y. Macotela, P. M. de Oca, F. Lopez-Barrera, G. Nava, J. L. Guerrero, A. Suarez, et al. Prolactin in Eyes of Patients with Retinopathy of Prematurity: Implications for Vascular Regression Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2049 - 2055. [Abstract] [Full Text] [PDF]

				Y. Oshima, C. Shukunami, J. Honda, K. Nishida, F. Tashiro, J.-i. Miyazaki, Y. Hiraki, and Y. Tano Expression and Localization of Tenomodulin, a Transmembrane Type Chondromodulin-I-Related Angiogenesis Inhibitor, in Mouse Eyes Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 1814 - 1823. [Abstract] [Full Text] [PDF]

				V. Asnaghi, C. Gerhardinger, T. Hoehn, A. Adeboje, and M. Lorenzi A Role for the Polyol Pathway in the Early Neuroretinal Apoptosis and Glial Changes Induced by Diabetes in the Rat Diabetes, February 1, 2003; 52(2): 506 - 511. [Abstract] [Full Text] [PDF]

				S. Yoshida, A. Yoshida, T. Ishibashi, S. G. Elner, and V. M. Elner Role of MCP-1 and MIP-1{alpha} in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization J. Leukoc. Biol., January 1, 2003; 73(1): 137 - 144. [Abstract] [Full Text] [PDF]

				J. Zhang, C. Gerhardinger, and M. Lorenzi Early Complement Activation and Decreased Levels of Glycosylphosphatidylinositol-Anchored Complement Inhibitors in Human and Experimental Diabetic Retinopathy Diabetes, December 1, 2002; 51(12): 3499 - 3504. [Abstract] [Full Text] [PDF]

				R. Ohashi, A. Shimizu, Y. Masuda, H. Kitamura, M. Ishizaki, Y. Sugisaki, and N. Yamanaka Peritubular Capillary Regression during the Progression of Experimental Obstructive Nephropathy J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1795 - 1805. [Abstract] [Full Text] [PDF]

				A. N. Witmer, H. G. Blaauwgeers, H. A. Weich, K. Alitalo, G. F. J. M. Vrensen, and R. O. Schlingemann Altered Expression Patterns of VEGF Receptors in Human Diabetic Retina and in Experimental VEGF-Induced Retinopathy in Monkey Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 849 - 857. [Abstract] [Full Text] [PDF]

				H. Funaki, S. Sawaguchi, K. Yaoeda, Y. Koyama, E. Yaoita, S. Funaki, M. Shirakashi, Y. Oshima, C. Shukunami, Y. Hiraki, et al. Expression and Localization of Angiogenic Inhibitory Factor, Chondromodulin-I, in Adult Rat Eye Invest. Ophthalmol. Vis. Sci., May 1, 2001; 42(6): 1193 - 1200. [Abstract] [Full Text]

				G B ARDEN The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment Br. J. Ophthalmol., March 1, 2001; 85(3): 366 - 370. [Full Text]

				C. Gerhardinger, K. D. McClure, G. Romeo, F. Podestà, and M. Lorenzi IGF-I mRNA and Signaling in the Diabetic Retina Diabetes, January 1, 2001; 50(1): 175 - 183. [Abstract] [Full Text]

				H. Sone, B. K. Deo, and A. K. Kumagai Enhancement of Glucose Transport by Vascular Endothelial Growth Factor in Retinal Endothelial Cells Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1876 - 1884. [Abstract] [Full Text]

				N. Alikacem, T. Yoshizawa, K. D. Nelson, and C. A. Wilson Quantitative MR Imaging Study of Intravitreal Sustained Release of VEGF in Rabbits Invest. Ophthalmol. Vis. Sci., May 1, 2000; 41(6): 1561 - 1569. [Abstract] [Full Text]

				F. Podesta, G. Romeo, W.-H. Liu, S. Krajewski, J. C. Reed, C. Gerhardinger, and M. Lorenzi Bax Is Increased in the Retina of Diabetic Subjects and Is Associated with Pericyte Apoptosis in Vivo and in Vitro Am. J. Pathol., March 1, 2000; 156(3): 1025 - 1032. [Abstract] [Full Text] [PDF]